Background. Sialoadhesin (Sn; CD169) is a lectinlike receptor whose expression is restricted to subsets of tissue and inflammatory macrophages. We have previously identified accumulation of Snþ macrophages as an important marker of disease progression versus remission in rat mesangial proliferative nephritis. The current study examined the significance of Snþ macrophages in human proliferative glomerulonephritis. Methods. Frozen kidney sections from normal adult human kidney (n ¼ 4) and pediatric nephropathy (n ¼ 40) were stained for total macrophages (CD68þ cells), Snþ macrophages, CD3þ T-cells and collagen type I by immunofluorescence. Leukocyte infiltration and the severity of glomerular lesions and interstitial damage were scored. A second protocol biopsy was performed in 27 cases and clinical and biopsy-based data obtained. Results. Snþ macrophages were absent from glomeruli in normal adult human kidney and in thin basement membrane disease (n ¼ 4), but were detected in 4 of 9 cases of purpura nephritis; 7 of 17 IgA nephropathy; 5 of 5 membranoproliferative glomerulonephritis, and 5 of 5 lupus nephritis. Snþ macrophages were localized in areas of focal glomerular and interstitial damage. Two-colour immunostaining confirmed that Snþ cells are a subset of total CD68þ macrophages. The number of glomerular Snþ macrophages correlated with the degree of proteinuria and glomerular lesions (r ¼ 0.44, P ¼ 0.0045 and r ¼ 0.82, P<0.0001; respectively), while interstitial Snþ macrophages correlated with the degree of proteinuria and interstitial damage (r ¼ 0.59, P<0.0001 and r ¼ 0.75, P<0.0001; respectively). Combined immunostaining revealed that interstitial Snþ macrophages and CD3þ T-cells co-localized in areas of tubulointerstitial damage with increased type I collagen deposition. There was significant correlation between the number of interstitial Snþ macrophages and CD3þ T-cells (r ¼ 0.74, P<0.0001). Most patients responded to a 2 year period of glucocorticoid therapy with a reduction in proteinuria and glomerular lesions and this correlated with the reduction in the number of glomerular Snþ macrophages. Conclusion. This study has identified Snþ cells as a macrophage subset whose accumulation in the kidney correlates with proteinuria and histologic damage. These results, together with recent findings from animal studies, suggest that Snþ macrophages may play an important role in progressive renal disease.
Introduction
Macrophages have been implicated in the initiation and/or progression of most types of primary and secondary human glomerulonephritis [1] . In addition, many temporal studies in animal models of kidney disease have shown a clear association between macrophage accumulation and the development of renal injury [1] . Furthermore, the degree of macrophage accumulation is predictive of disease progression in IgA nephropathy and lupus nephritis [2, 3] . These studies suggest, but do not prove, a role of macrophages as mediators of renal injury. Indeed, macrophages can perform many different functions according to the local microenvironment in which they are present, such as a pro-inflammatory response to microbial infection, removal of apoptotic cells, downregulation of the innate/immune response, and tissue repair [4] . Indirect evidence that macrophages can induce kidney disease comes from animal studies in which different methods of macrophage depletion (with variable specificity) have resulted in reduced renal injury [1] . Direct evidence that macrophages can mediate renal injury has come from adoptive transfer studies in acute rat anti-GBM glomerulonephritis [5] . The importance of macrophage activation in this process has been demonstrated by the ability of interferon-gamma to augment macrophage-mediated renal injury [6] . Thus, while macrophage activation is clearly a critical aspect of renal injury in experimental kidney disease models, little is known of macrophage activation in human glomerulonephritis.
Although the precise mechanisms of macrophage activation within specific microenvironments is poorly understood, these cells can express a discrete set of surface receptors which are specific for their particular anatomical/functional location. Sialoadhesin (Sn; CD169) is one such receptor. Originally identified as an erythrocyte receptor expressed by subsets of ''activated'' macrophages, Sn has been characterized as a member of the immunoglobulin superfamily uniquely expressed by macrophages and is a prototypical member of the family of sialic acid binding proteins [7] . Sialoadhesin expression can be induced in macrophages by a variety of stimuli [8, 9] . Sialoadhesin expression is normally restricted to macrophages in lymphoid tissue [10, 11] ; however, accumulation of Snþ macrophages is observed in chronic inflammatory lesions such as in rheumatoid arthritis, multiple sclerosis and tumors [12, 13] .
We have previously demonstrated that both CD4þ T-lymphocytes and Snþ macrophages accumulate in glomeruli and contribute to the development of irreversible glomerular and interstitial damage in a rat model of chronic mesangioproliferative nephritis [13, 14] . These findings suggest that Snþ macrophages may contribute to disease progression in human chronic kidney diseases. Because of the highly restricted pattern of expression of Sn in phenotypically and functionally distinct subpopulations of macrophages, the Snþ macrophage subset may be an important player, or marker, in the progression of human chronic glomerulonephritis.
The aim of the present study was to determine whether Snþ macrophages are present in human proliferative glomerulonephritis, and if Snþ macrophages may play a role in disease progression.
Materials and methods

Patients
Thirty-six patients undergoing diagnostic renal biopsy at the Department of Pediatrics, Niigata University Medical and Dental Hospital, were examined. Patients gave informed consent for the use of renal biopsy tissue, in excess of that required for diagnostic purposes, to be used for research purposes. Disease categories were based on histologic examination of biopsy specimens with clinical findings used to help distinguish between Henoch-Scho¨nlein purpura nephritis (HSPN) and immunoglobulin A nephropathy (IgAN). Details of the patients are summarized in Table 1 . All patients underwent the first renal biopsy before commencing steroid treatment and most of the patients in the HSPN, IgAN and membranoproliferative glomerularnephritis (MPGN) groups underwent a second protocol biopsy 2 years (2.2± 0.4 years) later, before the completion of the treatment, and clinical data were collected at this time (Table 1) . Renal tissue from the uninvolved portion of adult renal carcinoma nephrectomies was used as normal tissue controls. Serum creatinine (sCr), creatinine clearance (CCr), and 24 h protein excretion were determined at the time of biopsy with assays performed by the Department of Biochemistry, Niigata University Medical and Dental Hospital.
Quantification of histologic damage in renal biopsies
For light microscopy, a part of the kidney was fixed with Carnoy's solution, embedded in paraffin and a section was stained with periodic acid-Schiff and periodic acid-methenamine silver. The specimens were reviewed and analysed by an independent anatomic pathologist who was blinded to the 
Immunofluorescence
Tissue samples for immunofluorescence studies were snapfrozen in pre-cooled n-hexane and stored at À70 C. Macrophages, T-lymphocytes and collagen type I were detected in 3 mm frozen sections by indirect immunofluorescence. The number of cells stained for Sn, CD68 or CD3 antigens were counted at least in 12 glomeruli per patient. Interstitial cells stained for Sn, CD68 or CD3 antigens were counted at least in nine high-power fields (Â400).
To examine whether Snþ cells also expressed the CD68 antigen (a pan macrophage marker), two-colour immunofluorescence studies were performed on tissue sections using HSn7D2 (anti-Sn; mouse IgG1) and Y1/82A (anti-CD68; mouse IgG2b) as primary antibodies followed by incubation of sections with FITC-conjugated anti-mouse IgG1 and TRITC-conjugated goat anti-mouse IgG2b. Interstitial fibrosis was detected by indirect immunofluorescence staining of collagen type I using AMCA-conjugated goat anti-rabbit IgGs as secondary antibody. Three-colour immunofluorescence staining using anti-Sn (HSn7D2), anti-CD3 (cris 7) and anti-collagen type I antibodies.
Statistical analyses
Comparisons were made between two groups by Mann-Whitney test (GraphPad 4.0, San Diego, CA). The Pearson single correlation analysis was used to compare quantification of glomerular, tubular and interstitial Sn, CD68 or CD3 staining with proteinuria. The Spearman correlation analysis was used to compare the number of glomerular or interstitial Sn, CD68 or CD3 cells with the degree of glomerular or interstitial damage, respectively. Data are shown as the mean±SD.
Results
Patients
All patients underwent renal biopsy before commencing treatments such as steroids and other immunosuppressants (Table 1) . No patients presented with renal dysfunction at the time of biopsy as assessed by serum creatinine levels and CCr except for one patient with lupus nephritis who presented with a slight reduction in CCr (73 ml/min/1.73). Most of the patients, except those with thin basement membrane disease (TBMD), presented with proteinuria, while 1 of 9 HSPN, 5 of 17 IgAN, 1 of 5 MPGN, and 1 of 5 lupus nephritis patients presented with nephrotic syndrome with proteinuria greater than 3.5 g/day.
Accumulation of Snþ macrophages in glomerulonephritis
Immunofluorescence staining revealed small numbers of Snþ cells in the interstitium of normal adult human kidney, but Snþ cells were absent from glomeruli ( Figures 1A, B and 2A) . However, patients with proliferative glomerulonephritis showed many glomerular and interstitial Snþ cells ( Fig. 1C-E) . Glomerular accumulation of CD3þ T lymphocytes was also observed in some patients with proliferative glomerulonephritis (Fig. 1F ). Glomerular accumulation of Snþ cells was not seen in adult normal kidney or in TBMD, but was observed in 4 of 9 cases of purpura nephritis (44%); 8 of 17 cases of IgA nephropathy (47%); 5 of 5 cases of MPGN (100%), and 5 of 5 cases of lupus nephritis (SLE) (100%). In contrast, significant glomerular accumulation of CD68þ macrophages was seen in all patients (Figure 2A ). In IgAN, glomerular Snþ cells were detected in only those patients with severe proteinuria (mean 2.7 g/day), and in 5 of 8 cases presenting with nephrotic syndrome (mean proteinuria of 3.8 g/day). In lupus nephritis, despite the variety of histological change (two with WHO class II, two with class III and one with class IV), Snþ cells were detected in all patients.
Sialoadhesinþ cells are a subset of CD68þ macrophages
Dual immunofluorescence staining revealed that Snþ cells also express CD68, a pan macrophage marker, confirming that Snþ cells are a subpopulation of macrophages ( Figure 3A-C) . Most of the glomerular macrophages in patients with MPGN or SLE expressed Sn, while only 30-40% of glomerular macrophages in HSPN or IgAN expressed Sn (Figure 2A ). In contrast, most interstitial CD68þ macrophages expressed Sn in all disease groups ( Figure 2B ).
Correlation of sialoadhesinþ cells with renal injury
Taking all patients as a single cohort, there was a significant correlation between the number of glomerular Snþ cells and the degree of proteinuria and glomerular lesions. There was also a significant correlation between the number of interstitial Snþ cells and the degree of proteinuria and interstitial damage ( Figure 4A-D) . In addition, the total number of CD68þ macrophages in the glomerular and interstitial compartments correlated significantly with proteinuria and tissue damage ( Figure 4E-H) . In contrast, the calculated CD68þSnÀ macrophage subset did not correlate with proteinuria or with glomerular or tubulointerstitial damage. CD68þ macrophages were identified within glomerular crescents, but only rare Snþ cells were seen in crescents. Whether this reflects that macrophages All patients received glucocorticoid-based immunosuppression, which reduced proteinuria in most cases and all patients maintained normal renal function (Table 1) . Patients with HSPN, IgAN or MPGN underwent a second, protocol biopsy which was analysed for leukocytes by immunofluorescence. As a single cohort, patients showed a significant reduction in proteinuria and glomerular lesions at the second biopsy, although tubulointerstitial damage was unaltered ( Figure 5A-C) . There was also a significant reduction in the number of glomerular and interstitial CD68þ total macrophages, Snþ macrophages and CD3þ T cells in response to glucocorticoid therapy ( Figure 5D-I) .
The change in the number of glomerular Snþ macrophages in response to glucocorticoid therapy correlated with the change in proteinuria and glomerular lesions seen in response to therapy (Table 3 ). In addition, the change in the number of glomerular CD68þ total macrophages and CD3þ T cells correlated with the change in proteinuria and glomerular lesions. Among the changes in the number of interstitial leukocyte populations, a significant correlation with the change in proteinuria was only seen with interstitial Snþ macrophages. The change in the number of interstitial leukocyte populations failed to correlate with change in tubulointerstitial damage ( Table 3) . The change in the number of the CD68þSnÀ macrophage subset did not correlate with the change in proteinuria or histologic damage. Of note, the number of glomerular Snþ cells correlated with the severity of proteinuria at the time of the second biopsy (r ¼ 0.59; P ¼ 0.0012), whereas the CD68þ, CD3þ and CD68þSnÀ cell populations failed to correlate.
Discussion
Macrophages have been implicated as mediators of renal injury in human glomerulonephritis based upon correlative studies at the time of biopsy and as predictors of disease progression [1] [2] [3] . However, macrophages are highly heterogeneous cells and have the potential to perform many functions, including those involved in tissue repair [4] . Thus, it has been proved to be difficult to attribute specific functions to the macrophage infiltrate seen in individual biopsies. Most studies examining macrophage functional heterogeneity have been performed in vitro using functional bioassays or altered expression of individual gene products in bone marrow-derived macrophages or blood monocytes. A few studies have examined macrophage subsets in human glomerulonephritis. One such study found that the expression of the S100 family members, MRP8 and MRP14, and the formation of MRP8/MRP14 complexes in glomerular macrophages correlated with the severity of the inflammatory process [15] . In a separate study examining the T-cell co-stimulation molecule CD86, glomerular and interstitial CD86þ cells were found to be at least 60% macrophages. Interstitial CD86þ cells, but not glomerular CD86þ cells, were found to correlate with renal dysfunction [16] .
There are very few examples of molecules that can be used as specific markers of macrophage 'activation' in the setting of the renal biopsy. Sialoadhesin is one candidate marker of macrophage 'activation' since: (i) Sn expression is restricted to the macrophage lineage; (ii) Sn is not expressed by blood monocytes, (iii) Sn expression is induced by pro-inflammatory cytokines, and; (iv) Snþ macrophages can present antigen to T-cells.
In the current study, glomerular and interstitial Snþ macrophages were present in greatest numbers in the more severe types of glomerulonephritis (MPGN and lupus nephritis), but were only seen in approximately half of the cases of IgAN and purpura nephritis. The number of glomerular and interstitial Snþ macrophages showed a significant correlation with proteinuria and histologic damage. Glucocorticoid-based therapy of patients with HSPN, IgAN and MPGN was effective in reducing proteinuria and glomerular lesions. This response correlated with the change in the number of glomerular and interstitial Snþ macrophages. In addition, the degree of proteinuria observed after 2 years of glucocorticoid therapy correlated with the number of glomerular Snþ macrophages present in the second biopsy. These data suggest that Snþ macrophages may play a role in mediating renal injury and that this population is amenable to suppression by glucocorticoid therapy in these patients. However, these data do not rule out the possibility that the accumulation of Snþ macrophages simply reflects the severity of proteinuria, although the lack of correlation between the number of total CD68þ macrophages and the severity of proteinuria at the time of the second biopsy suggests that macrophage accumulation per se is not a simple response to renal injury. In support of a role for Snþ macrophages in mediating renal injury, we have previously demonstrated that glomerular accumulation of Snþ (ED3þ) associated with glomerular T-cell infiltration and production of interferon-g and interleukin-2 in a rat model of progressive mesangioproliferative glomerulonephritis [13] . Furthermore, depletion of CD4þ T-cells prevented glomerular accumulation of Snþ (ED3þ) macrophages and suppressed renal injury [14] . Sialoadhesin is normally restricted to a subset of tissue macrophages, such as those found in lymphoid tissue [7] . Since Sn is absent from blood monocytes, the expression of Sn by monocyte/macrophages within the diseased kidney must be induced by factors within the local glomerular and/or interstitial microenvironment. Combinations of the pro-inflammatory cytokines interferon-g, tumour necrosis factor-a and interleukin-1 can induce Sn expression in bone marrowderived macrophages, although when used individually these factors do not modulate Sn expression [9] . The most potent inducer of Sn expression in monocyte/ macrophages is glucocorticoids, and this induction is augmented by interferons b and g and interleukin-4 [8] . Thus, macrophage expression of Sn does not readily fit into one of the four modes of macrophage activation (innate, humoral, classical or alternative) [4] . The role of Snþ macrophages in disease has not been clearly elucidated. Since Sn is not a phagocytic receptor, it is unlikely to be involved directly in scavenging functions [7] . Recent studies have been suggested that Sn contributes to macrophage cell-cell and cell-matrix interactions during inflammatory reactions [11] . In particular, Sn has been identified as a lymphocyte adhesion molecule [17] , suggesting that Snþ macrophages may contribute to the recruitment of lymphocytes into inflamed tissues. In addition, a recent study has demonstrated that Snþ macrophages play an important role in the induction of T-cell immunity [18] . Using a mouse model of T-cell-mediated graft versus leukaemia, the T-cell response to eradicate the tumour was dependent upon Snþ macrophages as shown by administration of an anti-Sn antibody.
In vivo, Snþ host macrophages in the liver formed clusters with donor CD8þ T cells. In vitro, purified Snþ macrophages were shown to process exogenous antigens and stimulate MHC class I peptide-restricted CTL responses [18] . Our study showed that Snþ macrophages and CD3þ T cells co-localized in areas of tubulointerstitial damage with increased type I collagen deposition, and there was a significant correlation between the number of Snþ macrophages and CD3þ T-cells in both the glomerulus and interstitium. Thus, the leukocyte adhesion and antigen presentation functions of Snþ macrophages may promote T-cell immunity and chronic disease progression in human glomerulonephritis. Clearly, further studies are needed to examine the functional capacities of Snþ macrophages for co-stimulation of renal T-cell immunity and inducing kidney damage.
Conclusions
This is the first study to identify the Snþ subset of 'activated' macrophages in human glomerulonephritis. Accumulation of Snþ macrophages correlated with the degree of proteinuria and histologic damage. In addition, the response to glucocorticoidbased therapy correlated with a reduction in the number of Snþ macrophages. These results, together with recent findings from animal studies, suggest that Snþ macrophages may play an important role in progressive renal disease. Further studies are warranted to elucidate the functional capacity of Snþ macrophages and their potential for mediating renal injury. 
